|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
27
|
|
pubmed:dateCreated |
2010-9-17
|
|
pubmed:abstractText |
Every year approximately 25% of women diagnosed with breast cancer are younger than 50 years of age, and almost 10% of them have a BRCA mutation. Not all potential carriers are identified by existing criteria for BRCA testing. We estimated the costs and benefits of different BRCA testing criteria for women with breast cancer younger than 50 years.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4214-20
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20733129-Adult,
pubmed-meshheading:20733129-Apoptosis Regulatory Proteins,
pubmed-meshheading:20733129-BRCA1 Protein,
pubmed-meshheading:20733129-BRCA2 Protein,
pubmed-meshheading:20733129-Breast Neoplasms,
pubmed-meshheading:20733129-Computer Simulation,
pubmed-meshheading:20733129-Cost-Benefit Analysis,
pubmed-meshheading:20733129-Female,
pubmed-meshheading:20733129-Genetic Testing,
pubmed-meshheading:20733129-Health Care Costs,
pubmed-meshheading:20733129-Humans,
pubmed-meshheading:20733129-Life Expectancy,
pubmed-meshheading:20733129-Middle Aged,
pubmed-meshheading:20733129-Models, Economic,
pubmed-meshheading:20733129-Monte Carlo Method,
pubmed-meshheading:20733129-Mutation,
pubmed-meshheading:20733129-Patient Selection,
pubmed-meshheading:20733129-Practice Guidelines as Topic,
pubmed-meshheading:20733129-Predictive Value of Tests,
pubmed-meshheading:20733129-Quality-Adjusted Life Years,
pubmed-meshheading:20733129-Time Factors,
pubmed-meshheading:20733129-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Expanding the criteria for BRCA mutation testing in breast cancer survivors.
|
|
pubmed:affiliation |
Division of Gynecologic Oncology, University of British Columbia and British Columbia Cancer Agency, Vancouver, British Columbia, Canada. jkwon@post.harvard.edu
|
|
pubmed:publicationType |
Journal Article
|
